Hexagon Nutrition shareholders approve FY26 dividend at 33rd AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Hexagon Nutrition held its 33rd AGM on September 22, 2026, via video conferencing
  • Shareholders approved the declaration of dividend for FY26
  • Dr. Nikhil Arun Kelkar was re-appointed as Joint Managing Director
  • Remuneration revisions were approved for the Chairman, MD, and JMD
  • 42 members participated in the meeting, meeting quorum requirements
powered bylight_fuzz_icon
51635606

*this image is generated using AI for illustrative purposes only.

Hexagon Nutrition Limited held its 33rd Annual General Meeting on September 22, 2026, where shareholders approved key resolutions including the declaration of a dividend for FY26 and the reappointment of Dr. Nikhil Arun Kelkar as Joint Managing Director.

The meeting, conducted via video conferencing, commenced at 11:30 am and concluded at 12:22 pm. A total of 42 members participated through the virtual platform, satisfying the requisite quorum under the Companies Act, 2013. The proceedings were chaired by Arun Kelkar, Chairman and Executive Director.

Key resolutions passed

Shareholders voted on eleven agenda items, primarily focusing on financial approvals, director appointments, and remuneration revisions. The adoption of standalone and consolidated financial statements for FY26 was approved without qualifications from the statutory auditors.

The following significant resolutions were put to vote:

  • Adoption of standalone and consolidated financial statements for FY26
  • Declaration of dividend for FY26
  • Re-appointment of Dr. Nikhil Arun Kelkar (DIN: 02302369) as Joint Managing Director retiring by rotation
  • Appointment of Mr. Raghunath Sawant (DIN: 11863172) as Executive Director
  • Revision in remuneration for Chairman Arun Purushottam Kelkar, Managing Director Vikram Arun Kelkar, and Joint Managing Director Nikhil Arun Kelkar
  • Appointment of M/S. N. L. Bhatia & Associates as Secretarial Auditors
  • Ratification of remuneration to cost auditors for FY27
  • Alteration of articles of association regarding Malani Ventures Private Limited
  • Re-appointment of Arun Purushottam Kelkar as Chairman and Director

Board attendance and governance

The Board demonstrated strong engagement with both physical and virtual participation. The Chairman, Managing Director, Joint Managing Director, and additional director attended physically, while three independent directors joined virtually. The Company Secretary confirmed that no qualifications were noted in the Statutory Auditors' Report on the financial statements.

Role Name Attendance Mode
Chairman & Executive Director Arun Kelkar Physical
Managing Director Vikram Kelkar Physical
Joint Managing Director Nikhil Kelkar Physical
Additional Director Raghunath Sawant Physical
Independent Director Nimesh Shukla Physical
Independent Director Meena Mehta Physical
Chief Financial Officer Soman Jana Physical
Company Secretary Vedanti Vartak Physical
Independent Director Aparna Sakpal Virtual
Independent Director Keval Shah Virtual
Independent Director Payal Gagliani Virtual

Voting and compliance

E-voting was facilitated through NSDL, with Rachana Shanbhag of D. A. Kamat & Co. serving as the scrutinizer. Members who did not vote via remote e-voting prior to the meeting were given a 15-minute window during the session to cast their votes electronically. The voting results and the scrutinizer's report will be submitted separately to the stock exchanges.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-4.29%-7.32%+44.60%+44.60%+44.60%

How might the appointment of Mr. Raghunath Sawant as Executive Director influence Hexagon Nutrition's strategic direction in the nutraceutical sector?

What are the anticipated impacts of the revised remuneration structures for the Kelkar family leadership on shareholder sentiment and corporate governance ratings?

Given the clean statutory audit report, what specific growth metrics or market expansion plans did management highlight for FY27 during the Q&A session?

Hexagon Nutrition promoter acquires 5,000 shares in open market

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Dr. Nikhil Kelkar acquired 5,000 equity shares in Hexagon Nutrition via open market on September 18, 2026
  • Promoter stake increased from 17.28% to 17.29% following the transaction
  • Total equity share capital remains unchanged at 12,29,18,109 shares
  • Disclosure filed under Regulation 29(2) of SEBI SAST Regulations, 2011
powered bylight_fuzz_icon
51280332

*this image is generated using AI for illustrative purposes only.

Hexagon Nutrition disclosed that Dr. Nikhil Kelkar, its promoter and Joint Managing Director, acquired 5,000 equity shares through open market transactions on September 18, 2026.

The acquisition was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction represents a marginal increase in the promoter’s stake in the listed nutrition products manufacturer.

Shareholding Details

Prior to this transaction, Dr. Kelkar held 2,12,42,468 equity shares, constituting 17.28% of the total share and voting capital. The purchase of 5,000 additional shares raised his holding to 2,12,47,468 shares.

Metric Before Acquisition Acquisition After Acquisition
Number of Shares 2,12,42,468 5,000 2,12,47,468
% of Voting Capital 17.28% 0.0041% 17.29%

The total equity share capital of Hexagon Nutrition remained unchanged at 12,29,18,109 shares following the trade. There were no encumbrances, pledges, or convertible securities involved in this specific transaction.

Regulatory Compliance

The disclosure was submitted to both the National Stock Exchange of India Limited and BSE Limited. Vedanti Vartak, the Company Secretary and Compliance Officer, signed off on the filing on behalf of the company. Dr. Kelkar also submitted the requisite disclosure form directly to the exchanges.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-4.29%-7.32%+44.60%+44.60%+44.60%

Does this small-scale acquisition signal a broader strategy by Dr. Kelkar to increase his stake, or is it an isolated compliance-driven transaction?

How might this transaction influence retail investor sentiment regarding Hexagon Nutrition's promoter confidence and future stock price stability?

Are there any upcoming corporate actions or strategic shifts at Hexagon Nutrition that could explain the timing of this open market purchase?

More News on Hexagon Nutrition

1 Year Returns:+44.60%